22157.jpg
Outlook on the Inhaled Nitric Oxide Global Market to 2026 - Featuring Getinge, Merck and Halma Among Others
April 21, 2021 05:48 ET | Research and Markets
Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Global Inhaled Nitric Oxide Market By Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory...
22157.jpg
Global Inhaled Nitric Oxide Market Report 2021: Opportunity Analysis and Industry Forecast, 2020-2027
March 24, 2021 09:13 ET | Research and Markets
Dublin, March 24, 2021 (GLOBE NEWSWIRE) -- The "Inhaled Nitric Oxide Market by Application, Acute Respiratory Distress Syndrome and Others: Global Opportunity Analysis and Industry Forecast,...
Prolacta logo_singlecolor.png
Prolacta’s 100% Human Milk-Based Fortifiers Lower the Risk of Multiple Complications and Death Among Preterm Infants, Compared to Fortifiers Made From Cow Milk, Says New Study
September 08, 2020 09:05 ET | Prolacta Bioscience
DUARTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a new...
Research Suggests Some Premature Infants May Go Home From the NICU Up To Three Weeks Earlier When Fed Prolacta’s 100% Human Milk-Based Nutritional Products; Those with Bronchopulmonary Dysplasia May Benefit the Most
July 30, 2020 09:05 ET | Prolacta Bioscience
DUARTE, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- A retrospective study indicates that premature infants’ stays in neonatal intensive care units (NICUs) are reduced anywhere from 4.5 to 22.9 days...
Prolacta logo_singlecolor.png
Multiple NICUs Showed Improved Growth & Lung Health in Premature Infants by Fortifying Feeds Safely in the First Days of Life with Prolacta’s 100% Human Milk-Based Fortifiers
July 14, 2020 09:05 ET | Prolacta Bioscience
DUARTE, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of an...
Prolacta logo_singlecolor.png
Preterm Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers Achieved Catch-Up Growth by Age 2 with Appropriate Neurodevelopmental Outcomes, Study Says
June 01, 2020 09:05 ET | Prolacta Bioscience
DUARTE, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a...
Prolacta logo_singlecolor.png
Head-to-Head Subgroup Analysis of Human Milk–Based Fortifiers Finds Significant Improvements in Health and Brain Growth Measure for Preemies Fed Mother’s Milk Plus Prolacta’s Fortifiers
May 12, 2020 09:05 ET | Prolacta Bioscience
DUARTE, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk–based nutritional products, announced today that a subgroup analysis...
Prolacta logo_singlecolor.png
UPDATE - Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
April 02, 2020 23:55 ET | Prolacta Bioscience
DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience,® the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...
Prolacta logo_singlecolor.png
Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
April 02, 2020 15:50 ET | Prolacta Bioscience
DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...
gmi 2018.png
Therapeutic Respiratory Devices Market worth over $21.5 billion by 2024: Global Market Insights, Inc.
June 28, 2018 06:00 ET | Global Market Insights, Inc
Sellbyville, Delaware, June 28, 2018 (GLOBE NEWSWIRE) -- Global Therapeutic Respiratory Devices Market is poised to exceed USD 21.5 billion by 2024; according to a new research report by Global...